1Y Close · As of Aug 26, 2026
HLB PANAGENE operates in the Pharmaceuticals sector.
Legal name: HLB PANAGENE Co., LTD.
In fiscal year 2025, HLB PANAGENE (046210) reported revenue of 15.0 billion KRW, up 14.0% from 13.2 billion KRW a year earlier.
Operating profit was -3.4 billion KRW and net income was -3.1 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 50.1 billion KRW, with a P/B of 0.69.
These figures can be verified in the DART filing (receipt no. 20260317000770).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 15.0B | -3.4B | -3.1B |
| 2024 | 13.2B | -1.4B | -2.1B |
| 2023 | 12.3B | -1.8B | -4.8B |
Recent Filings
Officer/Major Shareholder Ownership Report
Large Shareholding Report (General)
Semi-Annual Report (2026.06)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-27 | Officer/Major Shareholder Ownership Report |
| 2026-08-27 | Large Shareholding Report (General) |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-13 | Large Shareholding Report (General) |
| 2026-07-29 | Officer/Major Shareholder Ownership Report |